Panagis G et al. |
Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. |
2008 |
Curr Drug Abuse Rev |
pmid:19630731
|
Xiong W et al. |
Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. |
2008 |
Mol. Pharmacol. |
pmid:17993512
|
Hill MN et al. |
Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. |
2008 |
Hippocampus |
pmid:18058925
|
Rueda-Orozco PE et al. |
A potential function of endocannabinoids in the selection of a navigation strategy by rats. |
2008 |
Psychopharmacology (Berl.) |
pmid:17805517
|
Wise LE et al. |
Evaluation of fatty acid amides in the carrageenan-induced paw edema model. |
2008 |
Neuropharmacology |
pmid:17675189
|
Murillo-RodrÃguez E et al. |
The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. |
2008 |
Neuroscience |
pmid:18822353
|
Woo DH et al. |
Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). |
2008 |
Mol Pain |
pmid:18826653
|
Currie S et al. |
IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. |
2008 |
J. Mol. Cell. Cardiol. |
pmid:18692061
|
Turco MY et al. |
High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. |
2008 |
Hum. Reprod. |
pmid:18614613
|
Maccarrone M |
Anandamide as a marker of human disease. |
2008 |
JAMA |
pmid:18632539
|
Williams MA et al. |
The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor. |
2008 |
J. Physiol. (Lond.) |
pmid:18063665
|
Justinova Z et al. |
Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. |
2008 |
Biol. Psychiatry |
pmid:18814866
|
Correa F et al. |
Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). |
2008 |
Biochem. J. |
pmid:17961121
|
Taylor AH et al. |
The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. |
2007 Sep-Oct |
Hum. Reprod. Update |
pmid:17584820
|
Sakamoto Y et al. |
Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock. |
2007 Sep-Oct |
ASAIO J. |
pmid:17885340
|
D'Argenio G et al. |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. |
2007 |
J. Mol. Med. |
pmid:17396241
|
Holt S et al. |
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. |
2007 |
Eur. J. Pharmacol. |
pmid:17397826
|
Mahler SV et al. |
Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. |
2007 |
Neuropsychopharmacology |
pmid:17406653
|
Kopczyńska B |
The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats. |
2007 |
Life Sci. |
pmid:17379256
|
Ferrer B et al. |
Regulation of brain anandamide by acute administration of ethanol. |
2007 |
Biochem. J. |
pmid:17302558
|
Naidu PS et al. |
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. |
2007 |
Psychopharmacology (Berl.) |
pmid:17279376
|
Sun Y et al. |
Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. |
2007 |
Br. J. Pharmacol. |
pmid:17906680
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Ghasemi M et al. |
Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats. |
2007 |
Br. J. Pharmacol. |
pmid:17486141
|
Borsani E et al. |
AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain. |
2007 |
Brain Res. |
pmid:17459353
|
Sit SY et al. |
Novel inhibitors of fatty acid amide hydrolase. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17459705
|
Lory P and Chemin J |
Towards the discovery of novel T-type calcium channel blockers. |
2007 |
Expert Opin. Ther. Targets |
pmid:17465728
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Raduner S et al. |
Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. |
2007 |
J. Nat. Prod. |
pmid:17497806
|
Wang Y and Wang DH |
Neural control of blood pressure: focusing on capsaicin-sensitive sensory nerves. |
2007 |
Cardiovasc Hematol Disord Drug Targets |
pmid:17346127
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Rettori V et al. |
Endocannabinoids in TNF-alpha and ethanol actions. |
2007 |
Neuroimmunomodulation |
pmid:18073513
|
Rossi G et al. |
Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. |
2007 |
Endocrinology |
pmid:17110429
|
Cross-Mellor SK et al. |
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. |
2007 |
Psychopharmacology (Berl.) |
pmid:17111174
|
Ronco AM et al. |
Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid. |
2007 |
Pharmacology |
pmid:17114903
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Wheal AJ et al. |
Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. |
2007 |
Br. J. Pharmacol. |
pmid:17245361
|
Romero FA et al. |
Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17279740
|
Wang Y et al. |
Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17308041
|
Snider NT et al. |
Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17272674
|
Matta JA et al. |
TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. |
2007 |
J. Physiol. (Lond.) |
pmid:17038422
|
Solinas M et al. |
The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17210800
|
Hsu SS et al. |
Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. |
2007 |
Toxicology |
pmid:17222495
|
Harada N and Okajima K |
Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats. |
2007 |
Dig. Dis. Sci. |
pmid:17211693
|
Pisanti S et al. |
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. |
2007 |
J. Cell. Physiol. |
pmid:17192847
|
Ekins S et al. |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. |
2007 |
Drug Metab. Dispos. |
pmid:17194716
|
Schreiber D et al. |
Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. |
2007 |
Anal. Biochem. |
pmid:17196922
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|